新西兰2012-2015年流感疫苗预防ICU入院及减轻重症的效果
SHIVERS项目纳入2012-2015年新西兰成人急性呼吸道疾病患者,普通病房3034例、ICU 101例,采用检测阴性设计评估灭活流感疫苗效果。普通病房患者疫苗有效性37%(95%CI 23-48%),ICU患者82%(95%CI 45-94%)。接种疫苗者若仍感染,ICU入院风险降低59%(aOR=0.41,95%CI 0.18-0.96)。
要点
- 普通病房患者流感疫苗有效性37%(95%CI 23-48%),ICU患者82%(95%CI 45-94%)。
- 分层分析中ICU流感疫苗有效性点估计均>70%,且一致高于普通病房。
- 住院流感阳性者接种疫苗与ICU入院风险降低59%相关(aOR=0.41,95%CI 0.18-0.96)。
核心结论
- 灭活流感疫苗可预防流感相关ICU入院,在ICU场景中的有效性可能高于普通病房,并似乎可降低接种后仍感染者的重症风险。
研究设计与样本
- SHIVERS项目为检测阴性设计研究,2012-2015年纳入成人(≥18岁)急性呼吸道疾病患者,普通病房3034例、ICU 101例。
- 通过实时逆转录聚合酶链反应确认流感,比较流感阳性与阴性者的疫苗接种 odds,所有模型调整季节、距季节峰值周数及接种倾向评分。
主要发现
- 普通病房患者流感病毒确认率28%、疫苗接种记录率56%;ICU患者分别为41%和41%。
- 跨季节疫苗有效性:普通病房37%(95%CI 23-48%),ICU 82%(95%CI 45-94%)。
- 按季节、病毒(亚)型、有无慢性病及年龄<65岁和≥65岁分层,ICU流感疫苗有效性点估计均>70%且一致高于普通病房。
- 住院流感阳性者中,疫苗接种与ICU入院 odds 降低59%相关(aOR=0.41,95%CI 0.18-0.96),并与更短ICU住院时长相关,但与影像学确认肺炎或普通病房住院时长无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about inactivated influenza vaccine effectiveness (IVE) in preventing very severe disease, including influenza-associated intensive care unit (ICU) admissions. METHODS: The Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) project enrolled adults (aged ≥ 18 years) with acute respiratory illness (ARI) in general ward (GW) hospital settings (n = 3034) and ICUs (n = 101) during 2012-2015. IVE was assessed using a test-negative design comparing the odds of influenza vaccination among influenza positives vs. negatives (confirmed by real-time reverse transcription polymerase chain reaction). All models were adjusted for season, weeks from season peak, and a vaccination propensity score. RESULTS: Influenza virus infection was confirmed in 28% of GW hospital and 41% of ICU patients; influenza vaccination was documented for 56% and 41%, respectively. Across seasons, IVE was 37% (95% confidence intervals [CI] = 23-48%) among GW patients and 82% (95% CI = 45-94%) among ICU patients. IVE point estimates were > 70% against ICU influenza and consistently higher than IVE against GW influenza when stratified by season, by virus (sub)types, and for adults with or without chronic medical conditions and for both adults aged <65 and ≥65 years old. Among hospitalized influenza positives, influenza vaccination was associated with a 59% reduction in the odds of ICU admission (aOR = 0.41, 95% CI = 0.18-0.96) and with shorter ICU lengths of stay (LOS), but not with radiograph-confirmed pneumonia or GW hospital LOS. CONCLUSION: Inactivated influenza vaccines prevented influenza-associated ICU admissions, may have higher effectiveness in ICU than GW hospital settings, and appeared to reduce the risk of severe disease among those who are infected despite vaccination.
引用
- Thompson MG, Pierse N, Sue Huang Q, et al. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015. Vaccine. 2018. PMID: 30077480. doi:10.1016/j.vaccine.2018.07.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。